Asia-Pacific HIV Therapeutics Market By Type (Nucleoside/tide Reverse Transcriptase Inhibitors Or Nucleoside/tide Analogues, Non-nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase [strand Transfer] Inhibitors, CCR5 Inhibitors, Fusion Inhibitors), Application (HIV Type-1&2)- And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Asia-Pacific HIV Therapeutics Market By Type (Nucleoside/tide Reverse Transcriptase Inhibitors Or Nucleoside/tide Analogues, Non-nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase [strand Transfer] Inhibitors, CCR5 Inhibitors, Fusion Inhibitors), Application (HIV Type-1&2)- And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 2076 | Pages: 135 | April 2018 | Region: Asia Pacific


Overview of the Market:
Asia-Pacific HIV Therapeutics Market was worth USD 2.33 billion in 2018 and estimated to be growing at a CAGR of 2.1%, to reach USD 2.59 billion by 2023. The human immunodeficiency virus (HIV) refers to a kind of retrovirus that causes (AIDS). HIV affects some immune cells and it weakens immune system bringing about loss of capacity to fight against the organisms that causes diseases.

HIV infection has no cure however there are medicines which help to balance out or decrease this infection so it doesn't prompt to AIDS. HIV therapeutics market is developing at a significant rate because of increment in the HIV infected cases and developing awareness about the same.

Major Driving factors are Increasing number of HIV affected cases, innovative advancement in HIV diagnosis and therapeutics, ascend in research exercises for developing HIV immunizations and not aware about the methods of transmission of the infection. Moreover, increase awareness about the accessibility of HIV therapeutics in the market and cost effective sedate treatments for HIV are driving the worldwide HIV therapeutics market. Be that as it may, different variables, for example, disappointment of treatment sometimes, absence of gifted experts and presentation of non-specific medications in the market are major restraints the HIV therapeutics market.

Geographical Analysis: 
The HIV Therapeutics Market is broadly categorized into Type (Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues, Non-nucleoside reverse transcriptase inhibitors, Protease inhibitors, Integrase [strand transfer] inhibitors, CCR5 inhibitors, Fusion inhibitors). And on the basis of Application (HIV Type-1&2). On the basis of geography, the Asia-Pacific market is analyzed under various regions namely Japan, China, Australia, India and South Korea. The Asian, African and South American areas are developing markets as of now contributing under 20% partake in the worldwide HIV market. The current development of the market in Asia Pacific is however a positive sign for potential makers, with whatever remains of the world after a comparable example. Asia Pacific is anticipated to be the fastest developing regional section and will hold its position over the forecast period inferable from the upgrading medicinal services foundation and presence of appropriate government activities favoring development.

Key Players in this Market: 
Some of the major Companies dominating the market, by their products and services include AbbVie, Inc., Bristol-Myers Squibb Company, Merck and Co., Inc., and Boehringer Ingelheim GmbH. Gilead Sciences, Inc. was the pioneer in HIV-1 therapeutics sector by considering market share and medication portfolio, took after by ViiV Healthcare in 2015. What's more, in the coming years other little players are required to enter this part with their pipeline drugs.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Drug Class                                                   

                                5.1.1 Introduction                                           

                                5.1.2 integrase inhibitor                                               

                                5.1.3 nucleoside/nucleotide reverse transcriptase inhibitor                                         

                                5.1.4  non-nucleoside turn around transcriptase inhibitor                                             

                                5.1.5 HIV-1 protease inhibitor                                    

                                5.1.6 pharmacokinetic enhancer                                              

                                5.1.7 passage inhibitor                                  

                                5.1.8  Y-o-Y Growth Analysis, Drug class                                                

                                5.1.9  Market Attractiveness Analysis, Drug class                                              

                                5.1.10  Market Share Analysis, Drug class                                              

                5.2 Application                                                 

                                5.2.1 Introduction                                           

                                5.2.2 HIV Type-1                                              

                                5.2.3 HIV Type-2                                              

                                5.2.4 Y-o-Y Growth Analysis, Application                                               

                                5.2.5 Market Attractiveness Analysis, Application                                             

                                5.2.6 Market Share Analysis, Application                                              

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 Drug Class                            

                                                6.1.3.3 HIV TYPE 1&2                      

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 Drug Class                            

                                                6.1.4.3 HIV TYPE 1&2                      

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 Drug Class                            

                                                6.1.5.3 HIV TYPE 1&2                      

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Athersys                                                      

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 StemCells                                                    

                8.3 Cryo Cell International                                                           

                8.4 Geron Corporation                                                  

                8.5 Mesoblast                                                   

                8.6 Aastrom Biosciences                                                              

                8.7 Celgene Corporation                                                              

                8.8 Invitrogen                                                   

                8.9 Cytori Therapeutics                                                 

                8.10 Retractable Technologies                                                   

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific HIV Therapeutics Market By Type, From 2018-2023 ( USD Million )
  2. Asia-Pacific Nucleoside/tide reverse transcriptase inhibitors or nucleoside/tide analogues Market By Region, From 2018-2023 ( USD Million )
  3. Asia-Pacific Non-nucleoside reverse transcriptase inhibitors Market By Region, From 2018-2023 ( USD Million )
  4. Asia-Pacific Protease inhibitors Market By Region, From 2018-2023 ( USD Million )
  5. Asia-Pacific Integrase [strand transfer] inhibitors Market By Region, From 2018-2023 ( USD Million )
  6. Asia-Pacific Fusion inhibitors  Market By Region, From 2018-2023 ( USD Million )
  7. Asia-Pacific HIV Therapeutics Market By Application, From 2018-2023 ( USD Million )
  8. Asia-Pacific HIV Type 1 Market By Region, From 2018-2023 ( USD Million )
  9. Asia-Pacific HIV Type 2 Market By Region, From 2018-2023 ( USD Million )
  10. Japan HIV Therapeutics Market By Type, From 2018-2023 ( USD Million )
  11. Japan HIV Therapeutics Market By Application, From 2018-2023 ( USD Million )
  12. China HIV Therapeutics Market By Type, From 2018-2023 ( USD Million )
  13. China HIV Therapeutics Market By Application, From 2018-2023 ( USD Million )
  14. India HIV Therapeutics Market By Type, From 2018-2023 ( USD Million )
  15. India HIV Therapeutics Market By Application, From 2018-2023 ( USD Million )
  16. Australia HIV Therapeutics Market By Type, From 2018-2023 ( USD Million )
  17. Australia HIV Therapeutics Market By Application, From 2018-2023 ( USD Million )
  18. South Korea HIV Therapeutics Market By Type, From 2018-2023 ( USD Million )
  19. South Korea HIV Therapeutics Market By Application, From 2018-2023 ( USD Million )
Middle-East & Africa Cardiovascular Therapeutic Drugs By Disease (Arteriosclerosis, Cardiac Arrhythmias, Myocardial Infarction, Acute Coronary Syndrome, Peripheral Artery Disease, Coronary Artery Disease, Hypertensi...
Middle East And Africa Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail...
Latin America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Asia Pacific Clostridium Botulinum Market By Product (botulinum Toxin Type A And Botulinum Toxin Type B), By End User (aesthetic And Therapeutics), By Distribution Channel (hospitals, Clinics And Retail Pharmacies) ...
Europe Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And...
North America Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmaci...
Clostridium Botulinum Market By Product ( Botulinum Toxin Type A And Botulinum Toxin Type B), By End User ( Aesthetic And Therapeutics), By Distribution Channel ( Hospitals, Clinics And Retail Pharmacies) And By Reg...
The Dental Bone Graft Substitutes Market Is Predicted To Reach USD 664.3 Million With A CAGR Of 9.8% According To Market Data Forecast Report....
Middle East And Africa Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal D...
Latin America Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Reg...
Asia-Pacific Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Rege...
Europe Dental Bone Graft Substitutes Market By Type ( Synthetic Bone Graft, Xenograft, Allograft And Demineralised Allograft) , By Application ( Socket Preservation, Ridge Augmentation, Periodontal Defect Regenerati...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.